Procaps Group S.A. (PROCF)

OTCMKTS · Delayed Price · Currency is USD
1.120
-0.210 (-15.79%)
Feb 21, 2025, 4:00 PM EST
-67.06%
Market Cap 126.36M
Revenue (ttm) 414.10M
Net Income (ttm) 52.20M
Shares Out 112.82M
EPS (ttm) 0.52
PE Ratio 2.17
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 580
Average Volume 45,178
Open 1.120
Previous Close 1.330
Day's Range 1.120 - 1.120
52-Week Range 0.774 - 1.630
Beta -0.05
RSI 38.48
Earnings Date May 2, 2025

About Procaps Group

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers ... [Read more]

Industry Pharmaceutical Preparations
Founded 1977
Employees 5,500
Stock Exchange OTCMKTS
Ticker Symbol PROCF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.